Fig. 1From: Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trialPatient flow through the study (overall population). COPD chronic obstructive pulmonary disease, BDP beclometasone dipropionate, FF formoterol fumarate, G glycopyrronium, BUD budesonide, ITT intention-to-treat, PP per protocolBack to article page